Latest On Theravance Biopharma, Inc (TBPH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 04:48 EST | News | Theravance Biopharma GAAP EPS of -$0.35 misses by $0.10, revenue of $10.4M misses by $3.3M | N/A |  |
| 2023-05-09 04:48 EST | News | Theravance Biopharma, Inc. (TBPH) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 04:48 EST | News | Theravance Biopharma, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-08 03:02 EST | News | Theravance Biopharma Q1 2023 Earnings Preview | N/A | |
| 2023-05-03 16:01 EST | News | Theravance Biopharma: Activist Pressure Might Lead To Substantial Capital Return | N/A | |
| 2023-04-12 22:35 EST | News | Theravance Biopharma ticks higher amid appointment of new director | N/A | |
| 2023-03-08 16:37 EST | News | Theravance Biopharma, Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-28 10:24 EST | News | Theravance Biopharma Inc. (TBPH) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-27 20:18 EST | News | Theravance large shareholder demands strategic review, cost cutting | N/A | |
| 2023-02-27 20:18 EST | News | Theravance Biopharma Q4 results mixed, co to reduce headcount by about 17% | N/A | |
| 2023-02-27 06:19 EST | News | Theravance Biopharma Q4 2022 Earnings Preview | N/A | |
| 2023-02-14 14:02 EST | News | Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit | N/A | |
| 2022-11-10 23:59 EST | News | Theravance Biopharma GAAP EPS of -$0.21 misses by $0.18, revenue of $12.5M misses by $3.46M | N/A | |
| 2022-11-08 01:22 EST | News | Theravance Biopharma, Inc. (TBPH) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 01:22 EST | News | Theravance Biopharma, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-05 02:23 EST | News | Theravance Biopharma Q3 2022 Earnings Preview | N/A | |
| 2022-09-28 09:09 EST | News | Theravance to purchase $95M of ordinary shares | N/A | |
| 2022-09-19 12:29 EST | News | Theravance Biopharma announces $250M capital return program | N/A | |
| 2022-09-17 10:34 EST | News | Theravance Biopharma (TBPH) Investor Presentation - Slideshow | N/A | |
| 2022-08-07 11:55 EST | News | Theravance Biopharma, Inc.'s (TBPH) CEO Rick Winningham on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-06 00:27 EST | News | Theravance Biopharma, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-04 17:35 EST | News | Theravance Biopharma GAAP EPS of -$0.11, revenue of $11.1M | N/A | |
| 2022-08-04 02:31 EST | News | Theravance Biopharma Q2 2022 Earnings Preview | N/A | |
| 2022-07-13 21:49 EST | News | Royalty Pharma to buy royalty interest in Trelegy drug from Theravance, Innoviva for $1.3B | N/A | |
| 2022-05-07 08:39 EST | News | Theravance Biopharma, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-07 08:39 EST | News | Theravance Biopharma's (TBPH) CEO Rick Winningham on Q1 2022 Results -Earnings Call Transcript | N/A | |
| 2022-05-06 08:28 EST | News | Theravance Biopharma GAAP EPS of -$0.34 misses by $0.23, revenue of $13.2M misses by $1.28M | N/A | |
| 2022-05-05 11:15 EST | News | Theravance Biopharma Q1 2022 Earnings Preview | N/A | |
| 2022-04-04 23:51 EST | News | Theravance slips after setback for ampreloxetine in second Phase 3 hypotension trial | N/A | |
| 2022-03-10 22:39 EST | News | Theravance: All-Round Failure | N/A | |
| 2022-02-24 20:27 EST | News | Theravance Biopharma, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-24 02:37 EST | News | Theravance Biopharma GAAP EPS of -$0.43 misses by $0.12, revenue of $14.95M beats by $1.39M | N/A | |
| 2022-02-24 02:37 EST | News | Theravance Biopharma's (TBPH) CEO Rick Winningham on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 06:42 EST | News | Theravance Biopharma Q4 2021 Earnings Preview | N/A | |
| 2022-02-11 09:58 EST | News | GlaxoSmithKline speculated to be targeting possible acquisition of Theravance Bio | N/A | |
| 2022-01-15 21:11 EST | News | Theravance Biopharma (TBPH) Investor Prsentation - Slideshow | N/A | |
| 2022-01-13 05:15 EST | News | Theravance Biopharma continues slide; down another 12% today | N/A | |
| 2022-01-04 03:14 EST | News | Theravance up 9% on 3x higher than normal volume | N/A | |
| 2021-12-23 21:18 EST | News | Janssen terminates izencitinib deal with Theravance Biopharma | N/A | |
| 2021-11-16 08:41 EST | News | Theravance Biopharma halts mid-stage Crohn’s disease study | N/A | |
| 2021-11-15 13:37 EST | News | Baupost continues cutting position in eBay, Intel, adds Theravance Biopharma and Verint Systems | N/A | |
| 2021-11-04 17:19 EST | News | Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 19:51 EST | News | Theravance Biopharma EPS beats by $0.08, misses on revenue | N/A | |
| 2021-11-03 00:16 EST | News | Theravance Biopharma Q3 2021 Earnings Preview | N/A | |
| 2021-10-15 21:28 EST | News | Warning: TBPH is at high risk of performing badly | N/A | |
| 2021-09-22 07:48 EST | News | Theravance Bio loses a third on headcount cut to focus on respiratory disease portfolio | N/A | |
| 2021-09-22 07:48 EST | News | Theravance Bio's ampreloxetine misses primary endpoint in late-stage orthostatic hypotension study | N/A | |
| 2021-09-22 07:47 EST | News | Theravance Bio suffers double downgrade at JP Morgan after trial setback | N/A | |
| 2021-08-28 12:02 EST | News | Trillium, Triple-S lead weekly healthcare gainers amid acquisitions; Cassava Sciences lags | N/A | |
| 2021-08-24 11:06 EST | News | Theravance's izencitinib fails to meet main goal in mid-stage ulcerative colitis study | N/A | |
About Theravance Biopharma, Inc (TBPH):
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical trials for the treatment of rheumatoid arthritis, myelofibrosis, and ulcerative colitis, as well as for a range of inflammatory intestinal diseases, including ulcerative colitis and Crohn's disease. In addition, the company's product portfolio also comprise Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; TD-8236, an investigational, inhaled lung-selective pan-JAK inhibitor, which is Phase II clinical study for treatment of a range of inflammatory diseases; and TD-5202, an investigational, orally administered, gut-selective, irreversible JAK3 inhibitor that is in Phase I clinical study for treatment of inflammatory intestinal diseases. Further, it offers TRELEGY for the treatment of COPD; Velusetrag, an oral and investigational medicine for gastrointestinal motility disorders; and Selective 5-HT4 Agonist for treatment of gastrointestinal motility disorders. It has a licensing and collaboration agreements with Pfizer Inc., Viatris Inc., Janssen Biotech, Inc., Alfasigma S.p.A, and Takeda Pharmaceutical Company Limited. The company was incorporated in 2013 and is based in George Town, the Cayman Islands.
General
- Name Theravance Biopharma, Inc
- Symbol TBPH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 359
- Fiscal Year EndDecember
- IPO Date2014-05-16
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.theravance.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 17.93
- Enterprise Value Revenue 23.83
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.99
- Next Year EPS Estimate -$2.90
- Next Quarter EPS Estimate -$0.93
- Operating Margin -414%
- Return on Assets -42%
- Revenue 71.86 million
- Earnings Per Share -$4.05
- Revenue Per Share $1.15
- Gross Profit -189096000
- Quarterly Earnings Growth -36.5%
View More
Highlights
- Market Capitalization 1.26 billion
- EBITDA -238566000
- PE Ratio -8.09
- PEG Ratio -0.05
- Analyst Target Price $31.88
- Book Value Per Share -$2.42
View More
Share Statistics
- Shares Outstanding 64.33 million
- Shares Float 34.94 million
- % Held by Insiders 1912%
- % Held by Institutions 84.69%
- Shares Short 3.52 million
- Shares Short Prior Month 3.38 million
- Short Ratio 9.55
- Short % of Float 14%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 0.93
- 52 Week High $31.35
- 52 Week Low $14.48
- 50 Day Moving Average 19.24
- 200 Day Moving Average 18.1
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Theravance Biopharma, Inc (TBPH) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Theravance Biopharma, Inc (TBPH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-23 | $N/A | -$0.92 | -$1.02 | 9.48% |
| 2020-09-30 | 2020-11-05 | $N/A | -$1.16 | -$1.01 | -14.53% |
| 2020-06-30 | 2020-08-06 | $N/A | -$1.00 | -$1.04 | 3.38% |
| 2020-03-31 | 2020-05-06 | $19.86 million | -$1.40 | -$1.08 | -30.23% |
| 2019-12-31 | 2020-02-24 | $29.5 million | -$1.17 | -$1.11 | -5.22% |
| 2019-09-30 | 2019-11-05 | $12.43 million | -$1.05 | -$1.08 | 2.6% |
| 2019-06-30 | 2019-07-31 | $26.15 million | -$0.72 | -$1.22 | 41.14% |
| 2019-03-31 | 2019-05-07 | $5.34 million | -$1.32 | -$1.17 | -12.82% |
| 2018-12-31 | 2019-02-26 | $15.74 million | -$0.92 | -$1.05 | 12.21% |
| 2018-09-30 | 2018-11-06 | $12.84 million | -$1.10 | -$1.16 | 5.01% |
| 2018-06-30 | 2018-08-01 | $23.48 million | -$0.76 | -$1.21 | 36.98% |
| 2018-03-31 | 2018-05-08 | $8.32 million | -$1.22 | -$1.36 | 9.96% |
| 2017-12-31 | 2018-02-27 | $4.52 million | -$1.64 | -$1.19 | -38.11% |
| 2017-09-30 | 2017-11-07 | $-3725000 | -$1.27 | -$1.22 | -4.44% |
| 2017-06-30 | 2017-08-08 | $3.51 million | -$1.27 | -$1.16 | -9.48% |
| 2017-03-31 | 2017-05-09 | $3.09 million | -$1.27 | -$1.14 | -11.4% |
| 2016-12-31 | 2017-02-27 | $5.69 million | -$1.36 | -$1.06 | -28.3% |
| 2016-09-30 | 2016-11-08 | $19.08 million | -$0.73 | -$0.95 | 22.75% |
| 2016-06-30 | 2016-08-08 | $5.47 million | -$1.06 | -$1.12 | 5.36% |
| 2016-03-31 | 2016-05-09 | $18.41 million | -$1.10 | -$0.97 | -13.4% |
| 2015-12-31 | 2016-03-09 | $3.89 million | -$1.23 | -$1.62 | 23.84% |
| 2015-09-30 | 2015-11-09 | $10.7 million | -$1.40 | -$1.44 | 2.78% |
| 2015-06-30 | 2015-08-10 | $7.13 million | -$1.42 | -$1.51 | 5.96% |
| 2015-03-31 | 2015-05-07 | $20.4 million | -$1.29 | -$1.57 | 17.83% |
| 2014-12-31 | 2015-03-10 | $1.43 million | -$2.02 | -$1.70 | -18.82% |
| 2014-09-30 | 2014-11-06 | $6.34 million | -$1.72 | -$1.85 | 7.03% |
| 2014-06-30 | 2014-08-13 | $2.97 million | -$1.55 | $0.10 | -1650% |
Theravance Biopharma, Inc (TBPH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Theravance Biopharma, Inc (TBPH) Chart:
Theravance Biopharma, Inc (TBPH) News:
Below you will find a list of latest news for Theravance Biopharma, Inc (TBPH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Theravance Biopharma, Inc (TBPH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 604.99 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 286.06 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 1.58 | CALL | 0 | 1 | 201.48 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0.65 | CALL | 0 | 15 | 51.03 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.1 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.65 | PUT | 0 | 16 | 44.7 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 111.89 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 211.72 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 255.96 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 192.09 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 63.04 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0.35 | CALL | 0 | 56 | 54.84 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0.13 | CALL | 0 | 11 | 70.61 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.29 | PUT | 0 | 36 | 64.38 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 1.2 | PUT | 0 | 3 | 81.16 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 97.98 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 140.35 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 163.97 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 113.47 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | CALL | 0 | 0 | 118.01 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 4.93 | CALL | 0 | 2 | 169.15 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 2.11 | CALL | 0 | 8 | 80.06 | TRUE | 0 | 0 |
| 2024-09-20 | 10 | 0.79 | CALL | 0 | 120 | 39.1 | FALSE | 0 | 0 |
| 2024-09-20 | 12.5 | 0.25 | CALL | 0 | 11 | 48.96 | FALSE | 0 | 0 |
| 2024-09-20 | 15 | 0.2 | CALL | 0 | 36 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 17.5 | 0.1 | CALL | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 20 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 0.25 | PUT | 0 | 3 | 67.92 | FALSE | 0 | 0 |
| 2024-09-20 | 10 | 1 | PUT | 0 | 1 | 45.89 | TRUE | 0 | 0 |
| 2024-09-20 | 12.5 | 0 | PUT | 0 | 0 | 57.24 | TRUE | 0 | 0 |
| 2024-09-20 | 15 | 0 | PUT | 0 | 0 | 88.87 | TRUE | 0 | 0 |
| 2024-09-20 | 17.5 | 0 | PUT | 0 | 0 | 109.43 | TRUE | 0 | 0 |
| 2024-09-20 | 20 | 0 | PUT | 0 | 0 | 105.27 | TRUE | 0 | 0 |
Latest TBPH Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $8.65 |
| Jun 13, 2022 7:59 PM EST | 76 | $8.67 |
| Jun 13, 2022 7:59 PM EST | 24 | $8.67 |
| Jun 13, 2022 7:59 PM EST | 49 | $8.67 |
| Jun 13, 2022 7:59 PM EST | 14 | $8.655 |
Theravance Biopharma, Inc (TBPH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920076844/0001104659-20-076844-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000021545719005828/0000215457-19-005828-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000031506619001362/0000315066-19-001362-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000031506620001235/0000315066-20-001235-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000083423720006945/0000834237-20-006945-index.htm |
| 2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000083423720009221/0000834237-20-009221-index.htm |
| 2020-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000083423720010027/0000834237-20-010027-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000090221920000198/0000902219-20-000198-index.htm |
| 2020-06-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000090266420002367/0000902664-20-002367-index.htm |
| 2019-04-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1583107/000090342319000194/0000903423-19-000194-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000093247119005763/0000932471-19-005763-index.htm |
| 2019-03-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1583107/000104746919001474/0001047469-19-001474-index.htm |
| 2019-12-03 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1583107/000104746919006605/0001047469-19-006605-index.htm |
| 2020-02-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1583107/000104746920000779/0001047469-20-000779-index.htm |
| 2020-02-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1583107/000104746920000842/0001047469-20-000842-index.htm |
| 2020-03-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1583107/000104746920001736/0001047469-20-001736-index.htm |
| 2019-01-03 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919000559/0001104659-19-000559-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919001153/0001104659-19-001153-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919010698/0001104659-19-010698-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919011975/0001104659-19-011975-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919025719/0001104659-19-025719-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919027522/0001104659-19-027522-index.htm |
| 2019-05-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1583107/000110465919030144/0001104659-19-030144-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919033641/0001104659-19-033641-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919035514/0001104659-19-035514-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919036065/0001104659-19-036065-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919042791/0001104659-19-042791-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919060096/0001104659-19-060096-index.htm |
| 2019-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919069670/0001104659-19-069670-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465919076187/0001104659-19-076187-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920002317/0001104659-20-002317-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920003244/0001104659-20-003244-index.htm |
| 2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920008665/0001104659-20-008665-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000110465920018589/0001104659-20-018589-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920019582/0001104659-20-019582-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920024258/0001104659-20-024258-index.htm |
| 2020-03-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1583107/000110465920028602/0001104659-20-028602-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920029209/0001104659-20-029209-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920044850/0001104659-20-044850-index.htm |
| 2020-04-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1583107/000110465920048524/0001104659-20-048524-index.htm |
| 2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920053390/0001104659-20-053390-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920057426/0001104659-20-057426-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920071709/0001104659-20-071709-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920076844/0001104659-20-076844-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920080819/0001104659-20-080819-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920091481/0001104659-20-091481-index.htm |
| 2020-09-01 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1583107/000110465920101456/0001104659-20-101456-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920104553/0001104659-20-104553-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000110465920121807/0001104659-20-121807-index.htm |
| 2020-06-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1583107/000114036120014055/0001140361-20-014055-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001558/0001179110-19-001558-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001561/0001179110-19-001561-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001564/0001179110-19-001564-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001567/0001179110-19-001567-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001570/0001179110-19-001570-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001572/0001179110-19-001572-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001574/0001179110-19-001574-index.htm |
| 2019-02-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002018/0001179110-19-002018-index.htm |
| 2019-02-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002019/0001179110-19-002019-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002406/0001179110-19-002406-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002409/0001179110-19-002409-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002413/0001179110-19-002413-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002418/0001179110-19-002418-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002424/0001179110-19-002424-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002427/0001179110-19-002427-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002429/0001179110-19-002429-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002431/0001179110-19-002431-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002433/0001179110-19-002433-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019002435/0001179110-19-002435-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019003477/0001179110-19-003477-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005451/0001179110-19-005451-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005453/0001179110-19-005453-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005455/0001179110-19-005455-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005457/0001179110-19-005457-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005461/0001179110-19-005461-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005465/0001179110-19-005465-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005467/0001179110-19-005467-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005469/0001179110-19-005469-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005472/0001179110-19-005472-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005477/0001179110-19-005477-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006410/0001179110-19-006410-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006516/0001179110-19-006516-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006520/0001179110-19-006520-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006522/0001179110-19-006522-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006524/0001179110-19-006524-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006527/0001179110-19-006527-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006530/0001179110-19-006530-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006534/0001179110-19-006534-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006538/0001179110-19-006538-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006541/0001179110-19-006541-index.htm |
| 2019-06-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019007361/0001179110-19-007361-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019008497/0001179110-19-008497-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009783/0001179110-19-009783-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009785/0001179110-19-009785-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009788/0001179110-19-009788-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009790/0001179110-19-009790-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009792/0001179110-19-009792-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009794/0001179110-19-009794-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009796/0001179110-19-009796-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009798/0001179110-19-009798-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019009800/0001179110-19-009800-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012011/0001179110-19-012011-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012013/0001179110-19-012013-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012015/0001179110-19-012015-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012017/0001179110-19-012017-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012019/0001179110-19-012019-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012021/0001179110-19-012021-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012023/0001179110-19-012023-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012025/0001179110-19-012025-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012848/0001179110-19-012848-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001196/0001179110-20-001196-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001198/0001179110-20-001198-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001200/0001179110-20-001200-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001202/0001179110-20-001202-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001204/0001179110-20-001204-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001206/0001179110-20-001206-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001208/0001179110-20-001208-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001210/0001179110-20-001210-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001212/0001179110-20-001212-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002141/0001179110-20-002141-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002143/0001179110-20-002143-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002146/0001179110-20-002146-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002148/0001179110-20-002148-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002150/0001179110-20-002150-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002152/0001179110-20-002152-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002154/0001179110-20-002154-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002156/0001179110-20-002156-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020002158/0001179110-20-002158-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005293/0001179110-20-005293-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005295/0001179110-20-005295-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005297/0001179110-20-005297-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005299/0001179110-20-005299-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005301/0001179110-20-005301-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005304/0001179110-20-005304-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005307/0001179110-20-005307-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005320/0001179110-20-005320-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005323/0001179110-20-005323-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006521/0001179110-20-006521-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006524/0001179110-20-006524-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006526/0001179110-20-006526-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006528/0001179110-20-006528-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006530/0001179110-20-006530-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006532/0001179110-20-006532-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006535/0001179110-20-006535-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020006538/0001179110-20-006538-index.htm |
| 2020-07-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008051/0001179110-20-008051-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008053/0001179110-20-008053-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008540/0001179110-20-008540-index.htm |
| 2020-08-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008844/0001179110-20-008844-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009259/0001179110-20-009259-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009261/0001179110-20-009261-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009263/0001179110-20-009263-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009265/0001179110-20-009265-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009267/0001179110-20-009267-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009269/0001179110-20-009269-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009271/0001179110-20-009271-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009273/0001179110-20-009273-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009275/0001179110-20-009275-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009277/0001179110-20-009277-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009566/0001179110-20-009566-index.htm |
| 2019-10-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000119312519277660/0001193125-19-277660-index.htm |
| 2020-06-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000119312520176545/0001193125-20-176545-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000121390019002522/0001213900-19-002522-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000121390019002526/0001213900-19-002526-index.htm |
| 2019-11-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1583107/000121390019022536/0001213900-19-022536-index.htm |
| 2020-02-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1583107/000138713120001890/0001387131-20-001890-index.htm |
| 2020-02-27 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1583107/000138713120002259/0001387131-20-002259-index.htm |
| 2020-06-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1583107/000138713120005869/0001387131-20-005869-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1583107/000138713120005871/0001387131-20-005871-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000141057819001021/0001410578-19-001021-index.htm |
| 2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000141057819001106/0001410578-19-001106-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1583107/000141057819001459/0001410578-19-001459-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1583107/000155837019001346/0001558370-19-001346-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1583107/000155837019004767/0001558370-19-004767-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1583107/000155837019007084/0001558370-19-007084-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1583107/000155837019010487/0001558370-19-010487-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1583107/000155837020001644/0001558370-20-001644-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1583107/000155837020006021/0001558370-20-006021-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1583107/000155837020010023/0001558370-20-010023-index.htm |
| 2019-08-09 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1583107/999999999719006419/9999999997-19-006419-index.htm |
Theravance Biopharma, Inc (TBPH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Theravance Biopharma, Inc (TBPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1912%Institutional Ownership: 8469%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-03 | ANN BRADY | President, TBIL | Buy | 40,000.00 | 111,111.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001196/0001179110-20-001196-index.htm | ||
| 2019-02-05 | Rick E Winningham | Chief Executive Officer | Buy | 147,000.00 | 1,112,939.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001572/0001179110-19-001572-index.htm | ||
| 2020-02-03 | Andrew A. Hindman | SVP, Chief Financial Officer | Buy | 20,000.00 | 113,550.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001200/0001179110-20-001200-index.htm | ||
| 2020-02-03 | Rick E Winningham | Chief Executive Officer | Buy | 170,000.00 | 1,244,455.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001210/0001179110-20-001210-index.htm | ||
| 2020-07-27 | Andrew A. Hindman | SVP, Chief Financial Officer | Buy | 20,000.00 | 127,458.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008540/0001179110-20-008540-index.htm | ||
| 2020-09-01 | RICHARD A GRAHAM | SVP, Development | Buy | 27,500.00 | 135,125.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009566/0001179110-20-009566-index.htm | ||
| 2020-02-03 | Rick E Winningham | Chief Executive Officer | Buy | 168,000.00 | 1,412,455.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001210/0001179110-20-001210-index.htm | ||
| 2019-02-05 | Bradford J Shafer | EVP, Gen. Counsel, Secretary | Buy | 65,000.00 | 141,994.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001570/0001179110-19-001570-index.htm | ||
| 2019-12-12 | VIJAY SABESAN | SVP, Technical Operations | Sell | 1,027.00 | 21.03 | 21,597.91 | 145,253.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019012848/0001179110-19-012848-index.htm |
| 2019-04-30 | Alsup Laurie Smaldone | Director | Buy | 8,385.00 | 18,347.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005451/0001179110-19-005451-index.htm | ||
| 2019-02-05 | Bradford J Shafer | EVP, Gen. Counsel, Secretary | Buy | 47,250.00 | 189,244.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001570/0001179110-19-001570-index.htm | ||
| 2019-02-05 | BRETT K HAUMANN | SVP Clin Dev & Chief Med Ofc | Buy | 65,000.00 | 199,911.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001558/0001179110-19-001558-index.htm | ||
| 2019-04-30 | GEORGE M WHITESIDES | Director | Buy | 8,385.00 | 200,963.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005469/0001179110-19-005469-index.htm | ||
| 2020-02-03 | VIJAY SABESAN | SVP, Technical Operations | Buy | 65,000.00 | 210,253.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001206/0001179110-20-001206-index.htm | ||
| 2019-02-05 | KENNETH R PITZER | SVP, Prod Strat & Comm Plng | Buy | 65,000.00 | 223,074.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001567/0001179110-19-001567-index.htm | ||
| 2019-02-05 | PHILIP D WORBOYS | SVP, Translational Science | Buy | 65,000.00 | 227,380.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001574/0001179110-19-001574-index.htm | ||
| 2019-02-05 | SHARATHCHANDRA S HEGDE | SVP, Research | Buy | 65,000.00 | 229,997.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001561/0001179110-19-001561-index.htm | ||
| 2020-02-03 | Bradford J Shafer | EVP, Gen. Counsel, Secretary | Buy | 65,000.00 | 240,334.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001208/0001179110-20-001208-index.htm | ||
| 2019-02-05 | BRETT K HAUMANN | SVP Clin Dev & Chief Med Ofc | Buy | 47,250.00 | 247,161.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001558/0001179110-19-001558-index.htm | ||
| 2020-04-28 | Alsup Laurie Smaldone | Director | Buy | 6,635.00 | 24,982.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005293/0001179110-20-005293-index.htm | ||
| 2019-03-05 | SHARATHCHANDRA S HEGDE | SVP, Research | Sell | 5,690.00 | 24.50 | 139,405.00 | 264,444.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019003477/0001179110-19-003477-index.htm |
| 2019-03-04 | SHARATHCHANDRA S HEGDE | SVP, Research | Sell | 3,343.00 | 25.06 | 83,763.55 | 270,134.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019003477/0001179110-19-003477-index.htm |
| 2019-02-05 | KENNETH R PITZER | SVP, Prod Strat & Comm Plng | Buy | 47,250.00 | 270,324.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001567/0001179110-19-001567-index.htm | ||
| 2019-02-05 | PHILIP D WORBOYS | SVP, Translational Science | Buy | 47,250.00 | 274,630.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001574/0001179110-19-001574-index.htm | ||
| 2019-05-17 | Donal O'Connor | Director | Sell | 2,673.00 | 20.19 | 53,967.60 | 27,571.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006410/0001179110-19-006410-index.htm |
| 2019-02-05 | SHARATHCHANDRA S HEGDE | SVP, Research | Buy | 47,250.00 | 277,247.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001561/0001179110-19-001561-index.htm | ||
| 2019-02-05 | FRANK PASQUALONE | SVP, Chief Comm Ops Officer | Buy | 65,000.00 | 281,340.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001564/0001179110-19-001564-index.htm | ||
| 2020-08-21 | BRETT K HAUMANN | Chief Medical Officer | Sell | 25,000.00 | 18.29 | 457,240.00 | 282,810.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009263/0001179110-20-009263-index.htm |
| 2020-02-03 | Bradford J Shafer | EVP, Gen. Counsel, Secretary | Buy | 54,000.00 | 294,334.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001208/0001179110-20-001208-index.htm | ||
| 2020-02-03 | BRETT K HAUMANN | SVP Clin Dev & Chief Med Ofc | Buy | 65,000.00 | 296,276.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001198/0001179110-20-001198-index.htm | ||
| 2019-05-16 | Donal O'Connor | Director | Sell | 1,327.00 | 21.00 | 27,867.00 | 30,244.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019006410/0001179110-19-006410-index.htm |
| 2019-04-30 | Donal O'Connor | Director | Buy | 8,385.00 | 31,571.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005465/0001179110-19-005465-index.htm | ||
| 2020-02-03 | KENNETH R PITZER | SVP, Prod Strat & Comm Plng | Buy | 65,000.00 | 324,834.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001204/0001179110-20-001204-index.htm | ||
| 2019-02-05 | FRANK PASQUALONE | SVP, Chief Comm Ops Officer | Buy | 47,250.00 | 328,590.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001564/0001179110-19-001564-index.htm | ||
| 2020-02-03 | PHILIP D WORBOYS | SVP, Research & Transl Science | Buy | 65,000.00 | 329,855.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001212/0001179110-20-001212-index.htm | ||
| 2020-08-20 | PHILIP D WORBOYS | SVP, Research & Transl Science | Sell | 17,103.00 | 18.00 | 307,854.00 | 333,252.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020009277/0001179110-20-009277-index.htm |
| 2020-04-28 | Donal O'Connor | Director | Buy | 6,635.00 | 34,206.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005304/0001179110-20-005304-index.htm | ||
| 2019-04-30 | DEAN J MITCHELL | Director | Buy | 8,385.00 | 34,571.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005461/0001179110-19-005461-index.htm | ||
| 2019-04-30 | ERAN BROSHY | Director | Buy | 8,385.00 | 34,571.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005453/0001179110-19-005453-index.htm | ||
| 2020-02-03 | BRETT K HAUMANN | SVP Clin Dev & Chief Med Ofc | Buy | 54,000.00 | 350,276.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001198/0001179110-20-001198-index.htm | ||
| 2020-02-03 | KENNETH R PITZER | SVP, Prod Strat & Comm Plng | Buy | 54,000.00 | 378,834.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001204/0001179110-20-001204-index.htm | ||
| 2019-04-30 | PETER S RINGROSE | Director | Buy | 8,385.00 | 37,999.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005467/0001179110-19-005467-index.htm | ||
| 2020-02-03 | FRANK PASQUALONE | SVP, Chief Comm Ops Officer | Buy | 65,000.00 | 383,312.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001202/0001179110-20-001202-index.htm | ||
| 2020-02-03 | PHILIP D WORBOYS | SVP, Research & Transl Science | Buy | 54,000.00 | 383,855.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001212/0001179110-20-001212-index.htm | ||
| 2020-04-28 | DEAN J MITCHELL | Director | Buy | 6,635.00 | 41,206.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005301/0001179110-20-005301-index.htm | ||
| 2020-04-28 | ERAN BROSHY | Director | Buy | 6,635.00 | 41,206.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005295/0001179110-20-005295-index.htm | ||
| 2020-02-03 | FRANK PASQUALONE | SVP, Chief Comm Ops Officer | Buy | 54,000.00 | 437,312.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001202/0001179110-20-001202-index.htm | ||
| 2019-07-01 | Andrew A. Hindman | SVP, Chief Financial Officer | Buy | 50,000.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019008497/0001179110-19-008497-index.htm | ||
| 2019-04-30 | Robert V JR Gunderson | Director | Buy | 8,385.00 | 51,630.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005455/0001179110-19-005455-index.htm | ||
| 2019-04-30 | WILLIAM D YOUNG | Director | Buy | 8,385.00 | 51,695.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005472/0001179110-19-005472-index.htm | ||
| 2020-04-28 | Robert V JR Gunderson | Director | Buy | 6,635.00 | 58,265.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005297/0001179110-20-005297-index.htm | ||
| 2020-04-28 | WILLIAM D YOUNG | Director | Buy | 6,635.00 | 58,330.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005307/0001179110-20-005307-index.htm | ||
| 2019-04-30 | BURTON G MALKIEL | Director | Buy | 8,385.00 | 65,142.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005457/0001179110-19-005457-index.htm | ||
| 2020-04-28 | GEORGE M WHITESIDES | Director | Buy | 6,635.00 | 6,635.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005323/0001179110-20-005323-index.htm | ||
| 2020-04-28 | Susan Molineaux | Director | Buy | 6,635.00 | 6,635.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005320/0001179110-20-005320-index.htm | ||
| 2020-04-28 | BURTON G MALKIEL | Director | Buy | 6,635.00 | 71,777.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020005299/0001179110-20-005299-index.htm | ||
| 2020-07-01 | DEEPIKA PAKIANATHAN | Director | Buy | 8,067.00 | 8,067.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020008053/0001179110-20-008053-index.htm | ||
| 2019-04-30 | Susan Molineaux | Director | Buy | 8,385.00 | 8,385.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019005477/0001179110-19-005477-index.htm | ||
| 2020-02-03 | Andrew A. Hindman | SVP, Chief Financial Officer | Buy | 43,550.00 | 93,550.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911020001200/0001179110-20-001200-index.htm | ||
| 2019-02-05 | Rick E Winningham | Chief Executive Officer | Buy | 170,000.00 | 965,939.00 | https://www.sec.gov/Archives/edgar/data/1583107/000117911019001572/0001179110-19-001572-index.htm |